Jean-Frederic Viret

Jean-Frederic Viret currently serves as the Chief Financial Officer at NGM Biopharmaceuticals since November 2023. Their extensive career includes roles as Chief Financial Officer at Shasqi, Blade Therapeutics, Inc., Coherus BioSciences, diaDexus, Inc., and XDx, Inc., where responsibilities encompassed finance, accounting functions, investor relations, and corporate communications. Additionally, Jean-Frederic Viret held positions as Independent Board Member at Rubryc Therapeutics and President of JV Consulting. Academic credentials include an MBA in Finance and Accounting from Cornell Johnson Graduate School of Management, a Ph.D. in Molecular Biology from the University of Strasbourg, and a position as a Visiting Fellow in Molecular Biology at Harvard Kenneth C. Griffin Graduate School of Arts and Sciences.